Author Archives for UroLift

Teleflex Announces FDA Clearance for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc

January 8, 2020 2:23 am by UroLift

January 7, 2020 Minimally Invasive Procedure Now Available to Hundreds of Thousands More Men with Enlarged Prostate, Providing Safe and... Read More

Teleflex Announces Urology Times Article Highlighting the UroLift System as Providing a Superior Patient Experience for Treating Enlarged Prostate

September 16, 2019 7:46 am by UroLift

Minimally Invasive Treatment Options for BPH Remain Critical Due to Shortcomings of Surgery and Medication WAYNE, Pa. –Sept. 16, 2019... Read More

Teleflex Announces Publication of a Large Real-World Study Confirming Results from Controlled Clinical Studies of the UroLift® System

July 18, 2019 3:10 am by UroLift

Results from Multi-Center Study Support the Application of Minimally Invasive Treatment for Broader BPH Population WAYNE, Pa. – July... Read More

Teleflex announces Presentations about its UroLift® System treatment at the annual British Association of Urologists (BAUS) meeting

July 12, 2019 9:13 am by UroLift

The UroLift® System for the treatment of Benign Prostatic Hyperplasia (BPH) was the subject of three presentations at the Glasgow,... Read More

12-Month Results from Study of NeoTract’s UroLift® System for BPH in Men with an Obstructive Median Lobe Published in Prostate Cancer and Prostatic Diseases

January 8, 2019 5:58 am by UroLift

PLEASANTON, Calif. – December 14, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet... Read More

NeoTract Welcomes UK Government Announcement to Remove Barriers to Adoption of the UroLift® System for BPH Care for Every NHS Hospital in England

October 24, 2018 2:50 am by UroLift

A new Government scheme announced today selects the UroLift® System as one of seven innovations across all specialisms that are... Read More

NeoTract Announces Independent Analysis in UK Confirming Cost Effectiveness of UroLift® System Treatment for Benign Prostatic Hyperplasia (BPH)

June 7, 2018 12:35 pm by UroLift

WAYNE, PA – June 08, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet... Read More

NeoTract To Unveil New Clinical Data on the UroLift® System at American Urological Association 2018 Meeting

May 17, 2018 1:20 am by UroLift

PLEASANTON, Calif. – May 16, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet... Read More

NeoTract Inc. Announces Positive Five-Year Results for Minimally Invasive UroLift® System at American Urological Association 2017 Meeting

May 18, 2017 11:54 am by UroLift

PLEASANTON, Calif. and Boston – May 15, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs... Read More

NeoTract’s Minimally Invasive UroLift® System for Enlarged Prostate Now Shown to be Durable Through Five Years: Results from Pivotal L.I.F.T. Randomized Study Presented

March 27, 2017 8:00 am by UroLift

PLEASANTON, Calif. and LONDON – March 27, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs... Read More

1 2 3 … 5 Next »